Home NDC 52536-342 Lomustine
Product NDC 52536-342
11-digit product format 525360342
Labeler code 52536
Product ID 52536-342_934ec2f1-8c3f-4978-b712-33e98c4295a5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name lomustine
Dosage form CAPSULE, GELATIN COATED
Route ORAL
Labeler Wilshire Pharmaceuticals, Inc.
Application NDA017588
Marketing category NDA
Marketing start 2026-04-15
Substance LOMUSTINE
Active strength 100 mg/1
Pharmacologic classes Alkylating Activity [MoA], Alkylating Drug [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N017588-001 GLEOSTINE LOMUSTINE 10MG CAPSULE / ORAL AB RLD, Approved before 1982 N017588-002 GLEOSTINE LOMUSTINE 40MG CAPSULE / ORAL AB RLD, RS, Approved before 1982 N017588-003 GLEOSTINE LOMUSTINE 100MG CAPSULE / ORAL AB RLD, Approved before 1982 N017588-004 GLEOSTINE LOMUSTINE 5MG CAPSULE / ORAL RLD 2014-12-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL AB RLD, Approved before 1982 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL AB RLD, RS, Approved before 1982 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL AB RLD, Approved before 1982 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL AB RLD, Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL AB RLD, RS, Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL AB RLD, Approved before 1982 c2088c7a36db…2026-10-15 13:18:30 2026-09 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 c2088c7a36db…2026-09-14 22:38:34 2026-08 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL AB RLD, Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL AB RLD, RS, Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL AB RLD, Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL AB RLD, Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL AB RLD, RS, Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL AB RLD, Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL AB RLD, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL AB RLD, RS, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL AB RLD, Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL AB RLD, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL AB RLD, RS, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL AB RLD, Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL RLD, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL RLD, RS, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL RLD, Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL RLD, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL RLD, RS, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL RLD, Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL RLD, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL RLD, RS, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL RLD, Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017588-001 GLEOSTINE 10MG CAPSULE / ORAL RLD, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017588-002 GLEOSTINE 40MG CAPSULE / ORAL RLD, RS, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017588-003 GLEOSTINE 100MG CAPSULE / ORAL RLD, Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017588-004 GLEOSTINE 5MG CAPSULE / ORAL RLD 2014-12-19 03ed91905a0d…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Lomustine
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LOMUSTINE 100 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7BRF0Z81KG Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 197894 Internal RxNorm lookup 197895 Internal RxNorm lookup 197896 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 52536-342-05 Lomustine 5 in 1 BOTTLE CAPSULE, GELATIN COATED 5 2 52536-342-05 Lomustine 1 in 1 CARTON CAPSULE, GELATIN COATED 1 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Lomustine LOMUSTINE Wilshire Pharmaceuticals, Inc. 3c3637fc-4499-4331-a3c4-6969fc86704e 2026-02-12 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 017588 application number: NDA017588 ndc (product): 52536-342 Gleostine LOMUSTINE Azurity Pharmaceuticals, Inc. 3529fe2f-3c23-4862-bb20-b48026957082 2025-09-25 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 017588 application number: NDA017588 Gleostine LOMUSTINE NextSource Biotechnology, LLC 7f77526b-4c40-409c-82ea-d0f934d89cc2 2024-01-23 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 017588 application number: NDA017588
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 52536-342-05 52536034205 1 BOTTLE in 1 CARTON (52536-342-05) / 5 CAPSULE, GELATIN COATED in 1 BOTTLE 1 bottle 2026-04-15 No No Current